ALX ONCOLOGY HOLDINGS INC (ALXO)
US00166B1052 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 434.20M | |||
| Cash Equivalents | 14.04M | 22.41M | 48.80M | 363.70M | N/A | |||
| Marketable Securities | 143.40M | 160.33M | 217.40M | N/A | N/A | |||
| Receivables | 1.10M | 1.00M | N/A | N/A | 0.00 | |||
| Other Current Assets | 9.33M | 4.92M | 4.80M | 3.40M | 1.80M | |||
| Total Current Assets | 167.86M | 188.66M | 271.00M | 367.00M | 436.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 10.24M | 10.84M | 9.80M | 3.40M | 100.00K | |||
| Investments And Advances | 27.05M | 35.41M | 16.70M | N/A | N/A | |||
| Other Non-Current Assets | 7.49M | 7.64M | 9.00M | 9.80M | 0.00 | |||
| Total Non-Current Assets | 44.79M | 53.89M | 35.50M | 13.20M | 100.00K | |||
| TOTAL ASSETS | 212.65M | 242.55M | 306.50M | 380.20M | 436.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 914.00K | 728.00K | 300.00K | 400.00K | N/A | |||
| Accrued Expenses | 24.66M | 26.05M | 19.80M | 11.10M | 6.00M | |||
| Accounts Payable | 6.23M | 8.59M | 8.10M | 3.80M | 0.00 | |||
| Other Current Liabilities | 430.00K | 630.00K | 200.00K | N/A | 200.00K | |||
| Total Current Liabilities | 32.23M | 36.00M | 28.30M | 15.30M | 6.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 10.87M | 11.21M | 9.40M | 300.00K | 0.00 | |||
| Other Non-Current Liabilities | 5.36M | 5.63M | 5.30M | 1.60M | 0.00 | |||
| Total Non-Current Liabilities | 16.23M | 16.84M | 14.70M | 1.80M | 0.00 | |||
| TOTAL LIABILITIES | 48.45M | 52.84M | 43.00M | 17.10M | 6.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -521.85M | -486.27M | -325.50M | -202.00M | -118.50M | |||
| Additional Paid In Capital | 685.97M | 675.68M | 589.70M | 565.00M | 548.30M | |||
| Common Shares | 50.00K | 50.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 28.00K | 256.00K | -800.00K | N/A | N/A | |||
| Shares Outstanding | 50.28M | 49.95M | 40.90M | 40.60M | 39.80M | |||
| Tangible Book Value per Share | 3.27 | 3.80 | 6.44 | 8.94 | 10.80 | |||
| Total Shareholders' Equity | 164.19M | 189.71M | 263.50M | 363.00M | 429.80M | |||
| TOTAL LIABILITIES AND EQUITY | 212.65M | 242.55M | 306.50M | 380.20M | 436.10M | |||
| Statistics | ||||||||
| Debt/Equity | 0.07 | 0.06 | 0.04 | 0.00 | N/A | |||
| Current Ratio | 5.21 | 5.24 | 9.58 | 23.99 | 70.32 | |||
| Return On Assets (ROA) | -78.16% | -66.30% | -40.29% | -21.95% | -11.68% | |||
| Return On Equity (ROE) | -101.22% | -84.76% | -46.86% | -22.99% | -11.85% | |||
All data in USD